The health and lives of endocrine patients are at risk due to crucial drug shortages due to the humanitarian crisis in Nagorno-Karabakh (Republic of Artsakh)
Date: 31 August 2023
The European Society of Endocrinology and the European Society for Paediatric Endocrinology are in crisis consultation talks with partner societies in Armenia (Armenian Association of Paediatric Endocrinologists and the Armenian Association of Endocrinology) regarding urgent medical drug supply, required to secure the continued care of patients with endocrine disease in Nagorno-Karabakh (Republic of Artsakh).
There is a current urgent need for endocrine medications and supplies in the besieged region of Nagorno-Karabach (Republic of Artsakh). Specifically, the supplies of insulin are nearing depletion, and the population is out of injection needles, syringes and strips. Patients are currently re-using the (single-use) syringes for 7-10 days. In addition, currently there is a significant shortage of levothyroxine, hydrocortisone, cabergoline and other medications.
Now is already too late – The European and international endocrine community calls for immediate action on chemicals legislation as the only way forward to address Endocrine Disrupting Chemicals
Date: 07 June 2023
Brussels, Belgium 7 June 2023 – The call for action reverberated across the halls of the European Parliament as a diverse group of scientists, policy makers and interest organisations gathered in a packed room, to discuss how to address the gaps between science and legislation and "Shape an ambitious legislative framework for endocrine disruptors."
“Through such meetings with experts, we as policy makers can obtain valuable insight into the latest available science and benefit from it in our legislative work” MEP Sirpa Pietikäinen (EPP, Finland)
Endocrine Disrupting Chemicals (EDCs) remain a critical issue at the intersection of health and the environment. With their potentially severe and life-altering effects across almost all life stages, EDCs need strict regulation in order to protect human health and the environment. As of now, the gaps between science and legislation persist – but ongoing reviews of chemicals legislation are an opportunity to change this.
New research sheds light on how shift work may influence fertility
Date: 16 May 2023
Only four weeks of shift work-like patterns in female mice are enough to disrupt their biological clock and reduce fertility, according to research presented at the 25th European Congress of Endocrinology. The findings help scientists better understand how circadian disturbances impact female fertility, which could eventually lead to future prevention strategies for women working in non-standard work schedules.
The second European Hormone Day on 15 May 2023
Date: 15 May 2023
The Endocrine community joins forces on European Hormone Day to raise awareness of vital role of hormones in preventing and treating rare and chronic diseases.
Today, 15 May 2023, the European Society of Endocrinology (ESE), the European Hormone and Metabolism Foundation (ESE Foundation) and other partners are marking the second European Hormone Day.
Scientists create first humanised mouse model for rare genetic disease
Date: 15 May 2023
Mice with a defected human gene responsible for a rare genetic disease, called congenital adrenal hyperplasia, have been developed for the first time. The achievement, presented at the 25th European Congress of Endocrinology, may help to develop and bring new therapies for people with the most common type of congenital adrenal hyperplasia.
Severe hot flashes after menopause increase metabolic syndrome risk in women
Date: 14 May 2023
Women who experience more severe hot flashes after menopause are more likely to develop metabolic syndrome and high blood pressure, according to research presented at the 25th European Congress of Endocrinology in Istanbul. The findings of this long-term study highlight the importance of using hormone replacement therapy for menopause in these women.
Stress hormone during pregnancy may improve early language development in children
Date: 13 May 2023
High levels of the stress hormone cortisol during the third trimester of pregnancy may improve speech and language skills in the first 3 years of a child’s life, according to research presented at the 25th European Congress of Endocrinology in Istanbul. The findings help researchers further understand the role cortisol plays in both fetal and child development.
Steroids linked to long-lasting heart disease risk and worse quality of life
Date: 13 May 2023
Anabolic steroids not only can cause serious side effects during use, such as heart failure and depression, but can continue being harmful years after stopping, according to two studies presented at the 25th European Congress of Endocrinology in Istanbul. These studies, supported by the Novo Nordisk Foundation, were carried out by researchers from the Copenhagen University Hospital Rigshospitalet who investigated the impact of anabolic steroids in former users.
Low levels of vitamin D linked to long covid
Date: 13 May 2023
Long COVID risk has been found to increase with low levels of vitamin D, according to research presented at the 25th European Congress of Endocrinology in Istanbul. The findings suggest that individuals should have their vitamin D levels checked after COVID-19.
More than 400,000,000 European and International endocrine patients urge Brussels to take action on REACH revision.
Date: 03 April 2023
Brussels, Belgium 3 April 2023 - A broad coalition of endocrine patient representatives and experience experts for over 400,000,000 European and international patients have today called on EU legislators to publish the revised REACH proposal without any further delay and no later than June 2023.
Citing the urgent and immediate need to minimise exposure to Endocrine Disrupting Chemicals (EDCs) in the interest of public health, the patients insist that flaws in the REACH regulation must be addressed without delay. EDCs are not a compromise area, and extending the current legislation is required to fulfil the mentioned objectives.
The petition was launched by the Patient Advocacy Group of European Society of Endocrinology and signed until now by 8 international patient associations representing about 300 national patient organisations across the world and more than 40 national endocrine patient (informing) organisations. Together they represent the European and international endocrine patient community. The petition has been submitted to the European Commission.
More than 30.000 European and International endocrinologists urge Brussels to take action on REACH revision
Date: 14 March 2023
Brussels, Belgium 14 March 2023 - A broad coalition of over 30.000 European and international endocrine experts have today called on EU legislators to publish the revised REACH proposal without any further delay and no later than June 2023.
Citing the urgent and immediate need to minimise exposure to Endocrine Disrupting Chemicals (EDCs) in the interest of public health, the experts insist that flaws in the REACH regulation must be addressed without delay. EDCs are not a compromise area, and extending the current legislation is required to fulfil the mentioned objectives.
The petition was launched by the European Society of Endocrinology (ESE), the Endocrine Society (ES) and 42 European national and specialist endocrine societies. Together they represent the European and international endocrine research and clinical community. The petition has been submitted to the European Commission.
Supply of CRH (Corticorelin human) and GHRH (Somatorelin)
Date: 30 January 2023ESE has been informed that CRH (Corticorelin human) and GHRH (Somatorelin) are currently not being manufactured due to technical problems with the production line, and that no solution is currently anticipated by the single producer (Ferring Pharmaceuticals) in the short to medium term. Because CRH is important in the diagnosis of Cushing’s syndrome, ESE advises that the last available vials in each centre should be reserved for the most important diagnostic procedures. Considering the importance of CRH for the diagnosis of Cushing’s syndrome and the consequences of misdiagnosis of this severe disease, ESE underlines the importance of a solution being urgently needed to solve this problem and will closely monitor the situation. Below is a statement from Ferring Pharmaceuticals.
Chrousos named winner of Transatlantic Alliance Award
Date: 13 October 2022The Endocrine Society and the European Society of Endocrinology (ESE) have jointly awarded the 2023 Transatlantic Alliance Award - to Prof. George P. Chrousos, M.D., Sc.D. Chrousos is Professor Emeritus of Pediatrics and Endocrinology at National and Kapodistrian University of Athens (NKUA) School of Medicine in Athens, Greece. He also is the UNESCO Chair on Adolescent Health Care and the Director of the University Research Institute on Maternal and Child Health and Precision Medicine, both at the NKUA School of Medicine. The Transatlantic Alliance Award, which was launched in 2021, recognizes an international leader who has made significant advancements in endocrine research on both sides of the Atlantic - in Europe and the United States.
European Society of Endocrinology (ESE) strengthens call for action on endocrine disrupting chemicals with key interventions on Thyroid and Bisphenol
Date: 03 October 2022Endocrine disrupting chemicals (EDCs) are one of the most pressing health challenges of the 21st century. The European Commission holds annual forums gathering stakeholders to address this issue. Experts connected to the European Society of Endocrinology intervened about the importance of the thyroid pathway for EDCs and the impact of bisphenols as a group on children. The EDC Forum1 is a yearly gathering of experts from the public and corporate sectors, convened by the directorate general for Environment (DG ENV) of the European Commission. Participants share knowledge and best practices, pinpoint problems, and create synergies. Impact on hormone pathways should be considered holistically: The European Chemicals Agency and Member States have so far considered the properties of each EDC individually in assessments on their potential restriction. Endocrinologists look at endocrine pathways, such as the thyroid or the adrenal gland, for which it is important to look at not just the effect of not just one substance but the mix of substances that may interfere with this pathway. Thyroid disease is one of the most common endocrine diseases, impacting millions of people throughout Europe.2 Andreas Kortenkamp, ESE expert and Professor of Human Molecular Toxicology at Brunel University in London, described the vital research being conducted by Eurion, a research cluster focused on improving the detection of endocrine disruptors in Europe. Professor Kortenkamp explained the importance of thyroid hormones for healthy brain development. He highlighted that inadequate test methods and regulatory approaches fail to protect us from the dangers of chemical exposures to brain development. He explained that clinicians regard thyroid hormone changes as adverse, while current EU EDC criteria fail to recognise the adversity of such changes. He said: “The EDC criteria should be changed to classify thyroid hormone changes as adverse. This would bring regulation in line with clinical practice and achieve better protection.” Avoiding regrettable substitution: Bisphenol A has been recognised as a substance of very high concern (SVHC) due to its endocrine disrupting properties, since 2017. Therefore, many products marketed for babies are labelled “free from bisphenol A”. However, this has led to regrettable substitution to other bisphenol groups that were not yet recognised as EDCs but may share some of the same properties. Anne-Simone Parent, ESE expert and professor of Paediatric Endocrinology at the University of Liège in Belgium highlighted in her keynote speech the dangers of Bisphenol to our youngest. "I am pleased that the Commission announced that bisphenols will now be evaluated as a group rather than individually. This enables the process of determining which substances require regulatory action or additional data, and which chemicals do not require further action. Our common purpose should be to safeguard the most vulnerable people, particularly children," Professor Parent stated. The remainder of the year will be critical for chemical regulation due to the continued implementation of the Chemical Strategy for Sustainability, including reviews of significant policy files, such as REACH, CLP and the Cosmetics Products Regulation. With their active participation to the EDC Forum, ESE has highlighted the urgent necessity to further phase out endocrine disrupting chemicals that threaten human health. 1 https://environment.ec.europa.eu/events/fourth-annual-forum-endocrine-disruptors-2022-09-21_en 2 ESE White Paper Hormones in European Health Policies: How endocrinologists can contribute towards a healthier Europe.
First European Hormone Day underscores the importance of hormones and calls for policies aiming for improved hormone health
Date: 23 May 2022On 23 May 2022, the European Society of Endocrinology (ESE), together with the European Hormone and Metabolism Foundation – Foundation of the European Society of Endocrinology (ESE Foundation) and its partner societies are introducing European Hormone Day. European Hormone Day will work towards improving the general understanding of the role of hormones in health and disease and address the societal and health challenges caused by some of the most prevalent diseases we face today. On the occasion of this first European Hormone Day, ESE and the ESE Foundation are publishing a joint Declaration ‘Recognising the Key Role of Hormones in European Health: ‘The Milano 2022 Declaration’. Endorsed by 35 national or specialist endocrine societies, the Declaration calls for a stronger inclusion of the endocrine health perspective as an integral part of European health policies, as laid out in the ESE White Paper on Hormones in European Health Policies published in May 2021.
Body weight influences the chance of developing Polycystic Ovary Syndrome
Date: 23 May 2022A recent study found a clear relationship between obesity and the chance of developing polycystic ovary syndrome (PCOS). The team report obesity during childhood and teenage years are particularly vital to the disease’s development. This ground-breaking public health research was presented during the 24th European Congress of Endocrinology in Milan, Italy.
Effects of COVID-19 contamination on the thyroid gland are still present after one year, study finds
Date: 21 May 2022Severe COVID-19 disease affects thyroid function through a variety of mechanisms according to a new study from Dr. Ilaria Muller and colleagues from the University of Milan, Italy. The study followed patients with thyroid dysfunction correlated to COVID-19 disease for one year, to better characterise such thyroid involvement and to follow its evolution over time. Their study was presented during the 24th European Congress of Endocrinology in Milan.
Gender Affirming Hormone Therapy has a positive impact on well-being
Date: 21 May 2022New evidence shows that people who have undergone Gender Affirming Hormone Therapy (GAHT) report high grades of satisfaction with both the physical and psychological effects. A new study on this topic, carried out by researchers in Portugal, was presented at the 24th European Congress of Endocrinology in Milan, Italy.
Milk and water most efficient vehicles for absorbing vitamin D, study finds
Date: 21 May 2022According to a new study presented at the 24th European Congress of Endocrinology in Milan, Italy on vitamin D food fortification working better with water and milk than in juice. By measuring the maximum concentration over time, the researchers found bioavailability of vitamin D to be higher in milk and water.
Ramadan fasting can create complications for patients with endocrine diseases, according to three new studies
Date: 21 May 2022Fasting throughout the holy month of Ramadan is important for millions of people around the world. Endocrinologists from two different Moroccan institutions have through different approaches, discovered that Ramadan fasting might induce hormone imbalances in people with endocrine issues. Their three new studies were presented at the 24th European Congress of Endocrinology in Milan.
European Journal of Endocrinology Impact Factor continues its steep rise!
Date: 30 June 2021The European Society of Endocrinology’s (ESE) Journal the European Journal of Endocrinology (EJE) has reached its highest ever Journal Impact FactorTM (JIF) in the 2020 Journal Citation ReportsTM (JCR) announced today (30 June, 2021). It confirms a steady trend over the past years, making it a rising star and global leader in publishing clinical and translational endocrinology research. The highly respected Journal achieved an Impact Factor of 6.664, placing it as number 20 out of 145 in the JCR list of Endocrinology and Metabolism research journals in terms of Impact Factor. This underpins the leading role of ESE in fostering exchange and scientific discourse and promoting endocrinology.
Hormones and COVID-19
Date: 27 May 2021Studies reveal that social isolation and quarantine throughout the COVID-19 pandemic may have a detrimental impact on people living with pre-existing conditions. Results from a recent study from Dr. Chiara Simeoli from the Italy and Dr. Liana Jashi from Georgia show that social isolation and quarantine can have a detrimental impact on physical and mental health of people living with pre-existing conditions. Two studies recent studies have examined the impact of social isolation and quarantine for people living with diabetes in the Adjara Region of Georgia, and on patients with hypercortisolism in Italy. Both studies reported that social isolation during the pandemic caused significant psychological and/or physical distress on the observed individuals. The studies as presented at e-ECE 2021 on Wednesday 26 May at 14:00 CEST.
Date: 27 May 2021According to a new study, testosterone therapy may reduce non-alcoholic fatty liver disease in obese men with functional hypogonadism and type-2 diabetes. Results from a recent study from Dr Kristina Groti Antonic and her team from the University of Ljubljana, Slovenia, found that testosterone therapy may help obese men with functional hypogonadism and type-2 diabetes reduce the prevalence of non-alcoholic fatty liver disease (NAFLD). The two-year study found that therapy with testosterone undecanoate normalised testosterone levels, reduced NAFLD, and suppressed the symptoms of hypogonadism in men living with these conditions. The study was presented at e-ECE 2021 on Tuesday 25 May at 14:00 CEST.
Date: 27 May 2021New research suggests that night shift work is linked to menstrual irregularity and increased chance of developing endometriosis Results from a recent study from Dr. Narjes Nasiri-Ansari, Dr. Aggeliki Karapanagioti, and a team of colleagues under the guidance and supervision of Professor Eva Kassi from the National and Kapodistrian University of Athens, Greece, found that women working night shifts may be at a greater risk of menstrual irregularity and developing endometriosis. The research found that a marginal reduction in the expression of a person’s biological clock increased in REV-ERBb in ectopic compared to eutopic tissues. Prior to this research, there have been no previously published studies relating to the alterations in core clock-genes and the impact on women with endometriosis. The study was presented at e-ECE 2021 on Sunday 23 May at 19 CEST.
Date: 27 May 2021Results from a recent study from Dr Angelo Cignarelli from the University of Bari show that a very low-calorie ketogenic diet can help testosterone and sex hormone (SHBG) levels in overweight men. The study found that a recommended low-calorie ketogenic diet for four weeks led to significant decreases in body weight, fat mass and body mass index (BMI) and a substantial increase of total testosterone and SHBG levels. Testosterone is responsible for sexual and reproductive functions and plays a significant role in calorie utilisation and metabolism as well. The study was presented at e-ECE 2021 on Monday 24 May at 14:06 CET.
Diabetes and pregnancy
Date: 27 May 2021A long-term study shows strong links between gestational diabetes during pregnancy and type-1 and type-2 diabetes later in life Results from a long-term study from Dr. Kaisu Luiro of Helsinki University Hospital have found that women who experience gestational diabetes (GDM) when they are pregnant are more prone to developing type-1 and type-2 diabetes later in life. The study suggests that autoantibody testing should be considered for women who experience GDM which may predict the presence or risk of diabetes, in order to have a better understanding of their condition prognosis. The study was presented at e-ECE 2021 on Monday 24 May 2021 at 14:30 CEST.
ESE statement: COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
Date: 19 May 2021New expert statement confirms strong links between our hormones and COVID-19: The endocrine system is strongly involved in SARS-Cov-2 infection – so much so that evidence of an “endocrine phenotype” of COVID-19 has emerged, according to a statement by the European Society of Endocrinology (ESE) published in the journal Endocrine in April 2021. Leading endocrinology researchers looked into the evidence that has accumulated over the past year since the pandemic emerged, and consistently found evidence for links across a variety of endocrine conditions. This statement constitutes an update of a March 2020 statement that was of the earliest and most read pieces delineating the involvement of the endocrine system in COVID-19.
Hormones matter in EU health policy Experts and policymakers agree that endocrinology (the field of hormone-related diseases) has a critical role to play in multiple health policy areas
Date: 04 May 2021Brussels, 4 May 2021. Today, EU policymakers, experts, patient representatives and other stakeholders gathered online to discuss the role of hormones in our everyday life, its interlinkage with prevalent non-communicable diseases and the policy measures required to address the many challenges in this rapidly growing area of human health.
Studies show strong links between the endocrine system and COVID-19 incidence and mortality
Date: 15 September 2020COVID -19 and the interlinkages to endocrine and metabolic diseases was an important programme topic for the 2020 edition of the European Congress of Endocrinology. With 4675 attendees from 112 countries this is the premier European endocrine meeting. Over 5 days, panel sessions covered the science behind COVID 19 and endocrine and metabolic disorders, as well as e-consulting and e-support to endocrine patients in times of COVID-19.
Global Clinical Practice Guideline program to improve patient care
Date: 10 September 2020The Endocrine Society and the European Society of Endocrinology (ESE) have reached an historic agreement to jointly develop Clinical Practice Guidelines providing evidence-based recommendations for clinical care and practice.
Vitamin D levels in the blood can predict future health risks & death
Date: 09 September 2020Free, circulating vitamin D levels in the blood may be a better predictor of future health risks in aging men, according to a study being presented at e-ECE 2020. These data suggest the free, precursor form of vitamin D found circulating in the bloodstream is a more accurate predictor of future health and disease risk, than the often measured total vitamin D. Since vitamin D deficiency is associated with multiple serious health conditions as we get older, this study suggests that further investigation into vitamin D levels and their link to poor health may be a promising area for further research.
Skin lightening products linked to altered steroid hormone levels
Date: 09 September 2020Women who misuse corticosteroid creams for cosmetic skin lightening may be at risk of developing adrenal insufficiency, according to research presented at e-ECE 2020. Women that frequently used high strength steroid creams had significantly lower baseline cortisol levels, a sign of impaired cortisol function. Low cortisol and adrenal insufficiency is a serious condition that causes extreme fatigue and can even lead to death. These findings suggest that better education on the side effects of steroid creams is needed to prevent these women from seriously damaging their health.
Probiotics may help manage childhood obesity
Date: 09 September 2020Probiotics may help children and adolescents with obesity lose weight when taken alongside a calorie-controlled diet, according to a study being presented at e-ECE 2020. The study found that obese children who were put on a calorie-restricted diet and given probiotics Bifidobacterium breve BR03 and Bifidobacterium breve B632, lost more weight and had improved insulin sensitivity compared with children on a diet only. These findings suggest that probiotic supplements and a calorie-controlled diet may help manage obesity in the younger population and reduce future health risks, such as heart disease and diabetes.
Ghrelin may be an effective treatment for age-related muscle loss
Date: 09 September 2020The hormone, ghrelin, may help protect the elderly population from muscle loss, according to a study being presented at e-ECE 2020. The study found that administering a particular form of ghrelin to older mice helped to restore muscle mass and strength. As muscle-related diseases are a serious health concern in the elderly population, these findings suggest a potential new treatment strategy for muscle loss to enable the aging population to remain fit and healthy.
Evaluating hormone-related targets & risks associated with COVID-19
Date: 09 September 2020The evidence for hormone involvement in COVID-19 infection and treatment will be evaluated and discussed by endocrine experts in a dedicated COVID-19 session at e-ECE 2020. The European Society of Endocrinology’s annual meeting is going online 5-9 September 2020 and the e-ECE 2020 programme will feature cutting-edge science and the latest in clinical practice and patient care. This includes a new, dedicated COVID-19 session, where experts in the field will present, summarise and examine evidence for the role of the endocrine system and hormones in COVID-19 infection risk, disease severity and potential treatment.
Thyroid inflammation linked to anxiety disorders
Date: 09 September 2020Patients with autoimmune inflammation of their thyroid may be at greater risk of developing anxiety, according to a study being presented at e-ECE 2020. The study found that people with anxiety may also have inflammation in their thyroid gland that can be reduced by taking the non-steroidal anti-inflammatory, ibuprofen. These findings suggest that thyroid function may play an important role in the development of anxiety disorders and that thyroid inflammation should be investigated as an underlying factor in psychiatric disorders, such as anxiety.
COVID-19 severity is increased in patients with mild obesity
Date: 16 July 2020The risk of greater COVID-19 severity and death is higher in people with any obese body mass index (BMI), according to a study to be published in the European Journal of Endocrinology. The study findings showed that BMI over 30 was associated with a significantly higher risk of respiratory failure, admission to intensive care and death in COVID-19 patients, regardless of age, gender and other associated diseases. The current guidelines for identifying those at higher risk in the UK are set at a BMI of 40 but these data suggest people with BMI over 30 should also be classified as at risk.
Vitamin D supplementation may slow diabetes progression
Date: 25 July 2019Vitamin D supplementation may slow the progression of type 2 diabetes in newly diagnosed patients and those with prediabetes, according to a study published in the European Journal of Endocrinology. The study findings suggest that high-dose supplementation of vitamin D can improve glucose metabolism to help prevent the development and progression of diabetes.
Obesity risk may be increased by exposure to common environmental chemicals
Date: 21 May 2019Exposure to common every day chemicals, called phthalates, may increase the risk of metabolic disorders including obesity and diabetes, according to findings to be presented in Lyon, at the European Society of Endocrinology annual meeting, ECE 2019. The study found a correlation between levels of phthalate exposure and markers of impaired liver function, as well as indicators of increased risk of obesity, diabetes and cardiovascular diseases. These findings suggest that more actions may need to be taken to reduce people’s exposure to these potentially harmful, yet commonly used chemicals.
Setting fair regulations for top female athletes that have naturally higher testosterone levels
Date: 21 May 2019Top performing female athletes are more likely to have naturally occurring higher testosterone levels, which sporting regulations should take into account, according to findings to be presented in Lyon, at the European Society of Endocrinology annual meeting, ECE 2019. The researchers show that top female athletes are more likely to have higher testosterone levels and mild disorders, as well as more severe and rarer conditions that increase testosterone levels. These findings suggest that higher testosterone levels can enhance physical performance in women, to levels more comparable to male physiology, and raises questions on how to ensure fairness of competition in women’s sport.
Environmental toxins can impair sexual development and fertility of future generations
Date: 20 May 2019Exposure to environmental pollutants can cause alterations in brain development that affect sexual development and fertility for several generations, according to findings to be presented in Lyon, at the European Society of Endocrinology annual meeting, ECE 2019. The offspring of pregnant rats exposed to a mixture of common endocrine-disrupting chemicals (EDCs), at doses equivalent to those commonly experienced by people, showed impairments in sexual development and maternal behaviour that were passed on through several generations. These findings suggest that current levels of endocrine-disrupting chemicals in our environment may already be causing long-lasting harm and that people and agencies should take measures to minimise exposure.
Sleep problems in teenagers reversed in just one week by limiting screen use
Date: 20 May 2019Sleep in teenagers can be improved by just one week of limiting their evening exposure to light-emitting screens on phones, tablets and computers, according to findings to be presented in Lyon, at the European Society of Endocrinology annual meeting, ECE 2019. The study indicates that by simply limiting their exposure to blue-light emitting devices in the evening, adolescents can improve their sleep quality and reduce symptoms of fatigue, lack of concentration and bad mood, after just one week.
Breastfeeding reduces long-term risk of heart disease in mothers
Date: 19 May 2019Women who breastfed their babies are less likely to develop heart disease later in life, according to findings to be presented in Lyon, at the European Society of Endocrinology annual meeting, ECE 2019. The study also suggests that the protective effect on heart health is increased in women who breastfed for longer periods of time. These findings provide further evidence for the long-term health benefits of breastfeeding and that women should be encouraged to do so when possible.
Men ignore serious health risks of steroid abuse in pursuit of the body beautiful
Date: 19 May 2019Many men continue to abuse steroids despite knowing that they have serious, life-limiting and potentially lethal side effects, according to findings to be presented in Lyon, at the European Society of Endocrinology annual meeting, ECE 2019. The study findings indicate that men using anabolic steroids to improve strength and physical performance are often aware of the side effects but choose to continue taking them. This raises serious concerns not only for their own health but that of future generations, since side effects are known to damage sperm as well as increase the risk of sexual dysfunction, heart disease and liver damage.
Mentally tiring work may increase diabetes risk in women
Date: 13 March 2019Women who find their jobs mentally tiring are more likely to develop type 2 diabetes, according to a study published in the European Journal of Endocrinology. The study findings suggest that mentally draining work, such as teaching, may increase the risk of diabetes in women. This suggests that employers and women should be more aware of the potential health risks associated with mentally tiring work.
Oestrogens in cows’ milk are unlikely to pose a threat to adult health
Date: 27 October 2018Oestrogens found naturally in cows’ milk are likely to be safe for human consumption in adults, according to a new review published in the European Journal of Endocrinology. The review brings together scientific evidence from over a dozen rodent and human studies that examined the effects of ingesting oestrogen-containing cows’ milk on fertility and the risk of cancer development. The findings of the review suggest that the levels of oestrogens found naturally in milk are too low to pose health risks to adults, and that there is no need for public concern.
Diabetic patients are more at risk of death from alcohol, accidents and suicide
Date: 13 October 2018Diabetic patients are more likely to die from alcohol-related factors, accidents or suicide, according to a study published in the European Journal of Endocrinology. The study findings suggest that the increased risk of death from these causes may be related to the mental health of patients, which may be adversely affected by the psychological burden of living with and self-treating this debilitating disease, with potentially serious complications.
Transgender brains are more like their desired gender from an early age
Date: 22 May 2018Brain activity and structure in transgender adolescents more closely resembles the typical activation patterns of their desired gender, according to findings to be presented in Barcelona, at the European Society of Endocrinology annual meeting, ECE 2018. These findings suggest that differences in brain function may occur early in development and that brain imaging may be a useful tool for earlier identification of transgenderism in young people.
Walking a tightrope: universal thyroid testing could reduce pregnancy problems in some cases, but interfere with healthy pregnancies in others
Date: 22 May 2018Universal testing for thyroid function in pregnant women could reduce miscarriages and negative neurodevelopmental effects for the baby, but may also put healthy pregnancies at risk by prescribing unnecessary drugs to mothers. The debate ‘Pregnant women should be screened for thyroid hormones and antibodies’ will be held in Barcelona at the European Society of Endocrinology annual meeting, ECE 2018, where two experts take opposing views on whether all pregnant women should be tested for abnormal thyroid function, or if this should only be offered to high risk mothers.
Larger waistlines are linked to higher risk of vitamin D deficiency
Date: 21 May 2018Higher levels of belly fat are associated with lower vitamin D levels in obese individuals, according to data presented in Barcelona at the European Society of Endocrinology annual meeting, ECE 2018. The study reports that vitamin D levels are lower in individuals with higher levels of belly fat, and suggests that individuals, particularly the overweight with larger waistlines should have their vitamin D levels checked, to avoid any potentially health damaging effects.
Brain stimulation may reduce food cravings as obesity treatment
Date: 21 May 2018Stimulating the brain to alter its intrinsic reward system shows promise in the treatment of obesity, according to results presented in Barcelona at the European Society of Endocrinology annual meeting, ECE 2018. The technique has yielded positive results after just a single treatment session, revealing its potential to become a safer alternative to treat obesity, avoiding invasive surgery and drug side effects.
Minimising exposure to common hormone-disrupting chemicals may reduce obesity rates
Date: 20 May 2018Everyday products carry environmental chemicals that may be making us fat by interfering with our hormones, according to research presented in Barcelona at the European Society of Endocrinology annual meeting, ECE 2018. Following recommendations on how to avoid these chemicals could help minimise exposure and potentially reduce the risk of obesity and its complications.
Could intermittent fasting diets increase diabetes risk?
Date: 20 May 2018Fasting every other day to lose weight impairs the action of sugar-regulating hormone, insulin, which may increase diabetes risk, according to data presented in Barcelona at the European Society of Endocrinology annual meeting, ECE 2018. These findings suggest that fasting-based diets may be associated with long-term health risks and careful consideration should be made before starting such weight loss programmes.
Meeting between the European Society of Endocrinology and European Parliament representatives
Date: 06 March 2018The European Society of Endocrinology is presenting itself for the first time to the European Parliament in a meeting with representatives of the European Parliament. The main purpose of this meeting is to strengthen the understanding within the European Parliament of the role of hormones on people’s health, and the influence of the endocrine system on a wide range of both common and rare conditions.
Warm temperatures can lead to misdiagnosis of diabetes in pregnancy
Date: 23 January 2018Environmental temperatures of over 25 degrees are associated with a significant increase in the risk of being misdiagnosed with gestational diabetes during pregnancy, data published in the European Journal of Endocrinology suggests. Misdiagnosis of the condition could lead to unnecessary insulin treatment and avoidable distress for prospective mothers.
Guidelines for management of recurrent pituitary tumours recommend new drug as first line treatment
Date: 10 January 2018New guidelines for managing recurrent pituitary tumours identify the drug temozolomide, as first line chemotherapy treatment. The guidelines, published in the European Journal of Endocrinology and produced by the European Society of Endocrinology (ESE), include a series of recommendations aimed at improving survival rates and quality of life for patients, through early identification of tumours and more effective treatment strategies.
Treating PCOS with a combination of oral contraceptives and spironolactone does not increase the risk of diabetes or heart disease
Date: 15 September 2017In women with polycystic ovary syndrome (PCOS), the most effective treatment is a combination of the oral contraceptive pill (OCP) with an anti-androgen, which does not increase the risk of metabolic or cardiovascular complications, according to a study published in the European Journal of Endocrinology. The findings should lead to more women being prescribed the most effective treatment for their condition.
Additional hormone measurement reveals pregnant women at high risk of preeclampsia
Date: 29 May 2017An additional blood test for pregnant women accurately predicts which women with high thyroid function are at risk of developing preeclampsia, according to a study presented at the European Congress of Endocrinology. The findings may help identify high-risk pregnant women and potentially avoid unnecessary treatment that carries the risk of foetal abnormalities.
Stubborn gut bacteria offer insights into yo-yo dieting
Date: 30 May 2017Previously obese dieters may struggle to keep weight off because of poor gut bacteria diversity, according to a new study presented at the European Congress of Endocrinology.
Preterm babies with low birth weight may be at increased risk of osteoporosis
Date: 30 May 2017Adults who were born prematurely or at a below average weight are more likely to have weaker bones and an increased risk of fracture and osteoporosis later in life. This research, presented at the European Congress of Endocrinology, could lead to recommendations that high-risk individuals follow diets rich in calcium, vitamin D and protein, and undertake weight-bearing exercise.
Exposure to chemicals in plastic and fungicides may irreversibly weaken children's teeth
Date: 31 May 2017Chemicals commonly found in plastics and fungicides may be weakening children’s teeth by disrupting hormones that stimulate the growth of dental enamel, according to a new study presented at the European Congress of Endocrinology.
Running may be better than cycling for long-term bone health
Date: 31 May 2017Exercise that puts greater strain on bones, like running, may improve long-term bone health more effectively than non weight-bearing activities like cycling, conclude the authors of a new study measuring the hormones of mountain ultra-marathon runners. The results of the study were presented at the European Congress of Endocrinology.
Hormone treatment in transgender persons could shed light on role of sex hormones in bone density
Date: 31 May 2017Male-to-female (MtF) transgender persons have a greater increase in bone mineral density than female-to-male (FtM) persons in their first year of hormone treatment. The research, presented at the European Congress of Endocrinology in Munich, helps scientists further understand the roles sex hormones play on bone development and maintenance in both sexes.
Recommendations for the diagnosis and treatment of Adrenal Incidentalomas
Date: 12 July 2017The appropriate clinical response to adrenal incidentaloma should depend on the likelihood of malignancy, according to new guidelines published by the European Society of Endocrinology (ESE), in collaboration with the European Network for the Study of Adrenal Tumours (ENSAT) and first presented at ESE’s annual European Congress of Endocrinology in May 2016.
International collaboration release revised guideline for improved management of Turner syndrome
Date: 10 July 2017A comprehensive, international guideline that incorporates the most up-to-date knowledge on diagnosis, treatment and patient impact of Turner syndrome (TS) has been published in the European Journal of Endocrinology. The guideline project was initiated by the European Society of Endocrinology (ESE) and the Pediatric Endocrine Society (PES), in collaboration with six other learned societies, to incorporate the latest evidence-based advice for diagnosis and treatment of girls and women with TS.